2831-2840 of 4460 results
ACCC inquiry into the east coast gas market - key findings and recommendations
The final report of the ACCC inquiry into the east coast gas market was released today The ACCC has made recommendations about removing government moratoria on gas developments revising the test to determine when a pipeline should be regulated and increasing consistency and transparency in ...
Media ownership reform back in the spotlight
The Federal Government has introduced a narrow package of media ownership reform which if enacted will reduce the restrictions imposed by the Broadcasting Services Act on the ownership of media assets across platforms and market ...
Life insurance industry gets a remuneration Bill, ASIC report and Code of Practice
This is a significant week for the life insurance industry with the re-introduction by the Federal Government of a Bill to reform commissions payable on life insurance policies the release by ASIC of findings of its review of life insurance claims and the launch yesterday by the Financial Services ...
Implications for government acquiring agencies under NSW land acquisition reform
This insight examines the key changes to the NSW Governments' announcement to its intention to reform the land acquisition process in New South Wales. ...
Report: Wrap-Up of Sydney Arbitration Week 2016
The Allens Arbitration group reports on some highlights from Sydney Arbitration Week which examines the biggest challenges facing the future of international arbitration ...
Disclosing privileged documents to regulators
The case of Cantor v Audi provides insights into what you should consider before providing privileged documents to a regulator. ...
Financial Services Class Actions
Our class actions team recently published our Class Action Risk 2016 report The objective of the report is to look behind the headlines and hype that often surrounds class actions to provide a more holistic and objective assessment of class action risk for our clients This is particularly important ...
What's in a (biosimilar) name?
Because biosimilars and their reference biologic medicine are not identical whether compared to each other or even between biosimilars it is important to know which product has been used ...
Protecting investment in biologic medicines - biological medicines, biosimilars and the challenges they pose
This series of articles is directed towards the part of biotech that is pharmaceutical rather than diagnostic or bioengineering technologies and in particular towards biologic medicines ...
Not better late - the Prime Trust appeal judgment
The main Prime Trust appeal judgement is relatively well known but a trusts responsible entities and their officers should look at what the appeal court had to say on other related matters ...